The human polyomavirus, JCV, causes a demyelinating disease in immune compromised individuals, progressive multifocal leukoencephalopathy (PML). PML is a substantial neurological complication in AIDS patients, occuring in 8% of all cases. PML is the AIDS defining illness in almost 1% of AIDS cases. Although in the past PML was a rare disease, it now represents a large number of neurological disease and is considered on the increase by recent statistics from the CDC. JC Virus was orignially thought to be strictly neurotropic, infecting only macroglial cells derived from the human brain. However, our results have now shown that there is a firm link between lymphoid and glial cells in the pathogenesis of JCV infection leading to demyelination in the human brain. We have identified the nucleotide sequences from the viral regulatory region which are signature sequences in tonsil tissues, B lymphocytes in the tonsils, and stromal cells which make up the architecture of lymphoid organs. The data indicate that the same viral genotype which is found in brain tissue of PML patients originates from an initial lymphoid cell infection. This is the first evidence for a common route for JCV infection and establishes lymphoid cells as probable carriers of virus to other tissues. The molecular similarities between these cells for JCV gene expression and cells of the nervous system directly correlated with the expression of the NF-1 class D family of DNA binding proteins which function for transcription. We have cloned the gene for NF-1/D from human brain which is highly expressed. We have prepared polyclonal antibodies to each of the 4 classes of NF-1 and used these antibodies in gel shift experiments to identify class D proteins from both brain and lymphoid tissues. There appears to be a close association between susceptibility of infection to JCV and expression of this DNA binding protein. We have made expression vectors for NF-1/D and produced cell lines which constituitively express NF-1/D. These cell lines are normally non- permissive for JCV transcription. However, we have converted them from non-permissive to permissive once selected for NF-1/D expression. We have also cloned and expressed the viral virion protein, VP1, which is responsible for cell attachment and entry of the viral particle. We have developed the methodology to allow the VP1 molecules to self- assemble into icosahedron particles like a true virion particle. We add DNA of any origin into the self assembly process and can deliver genes to any cell type. Using this system, we have been able to definitively document that susceptibility to JCV infection in humans is directly related to transcriptional regulation by cells which express high levels of NF-1/D and not to attachment and entry of the viral particle. We are now investigating individual tissue samples from AIDS patients with PML and those without to determine NF-1/D expression levels and correlation with risk of developing PML. - JC Virus, lymphoid cell infection, demyelination PML, AIDS, transcription control, NF-1/D

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Intramural Research (Z01)
Project #
1Z01NS001983-28
Application #
6290609
Study Section
Special Emphasis Panel (LMMN)
Project Start
Project End
Budget Start
Budget End
Support Year
28
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Major, Eugene O (2009) Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies. Annu Rev Med :
Linda, Hans; von Heijne, Anders; Major, Eugene O et al. (2009) Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361:1081-7
Major, Eugene O (2009) Reemergence of PML in natalizumab-treated patients--new cases, same concerns. N Engl J Med 361:1041-3
Bohl, Daniel L; Brennan, Daniel C; Ryschkewitsch, Caroline et al. (2008) BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 43:184-9
Houff, Sidney A; Berger, Joseph; Major, Eugene O (2008) Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 199:160-161
Roseti, Livia; Facchini, Andrea; De Franceschi, Luciana et al. (2007) Induction of original phenotype of human immortalized chondrocytes: a quantitative gene expression analysis. Int J Mol Med 19:89-96
Ravichandran, Veerasamy; Jensen, Peter N; Major, Eugene O (2007) MEK1/2 inhibitors block basal and transforming growth factor 1beta1-stimulated JC virus multiplication. J Virol 81:6412-8
Ravichandran, Veerasamy; Major, Eugene O (2006) Viral proteomics: a promising approach for understanding JC virus tropism. Proteomics 6:5628-36
Li, Jongming; Melenhorst, Jos; Hensel, Nancy et al. (2006) T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol 87:2951-60
Yousry, Tarek A; Major, Eugene O; Ryschkewitsch, Caroline et al. (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924-33

Showing the most recent 10 out of 41 publications